| Overview |
| bsm-90049r-50µL |
| ACSL4 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ACSL4 |
| 650-691/711 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2182 |
| O60488 |
| ACSL4; Acyl-CoA Synthetase Long Chain Family Member 4; LACS4; ACS4; FACL4; Fatty-Acid-Coenzyme A Ligase Long-Chain 4; Long-Chain Fatty-Acid-Coenzyme A Ligase 4; Long-Chain-Fatty-Acid--CoA Ligase 4; Long-Chain Acyl-CoA Synthetase 4; Lignoceroyl-CoA Synthase; Arachidonate--CoA Ligase; EC 6.2.1.3; MRX63; MRX68; Mental Retardation X-Linked 63; Mental Retardation X-Linked 68; Acyl-CoA Synthetase 4; EC 6.2.1.15; XLID63; LACS 4 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz